Risk factors for early rebleeding after esophageal variceal ligation in patients with liver cirrhosis

Jin Yan; Wang Xue; Zhang LingJuan; Qiu Ting; Shang BoXin; Lian XiaoYan; Yan ChunYing; Duan TianJiao; Zhang Rong; Liu GuiSheng

doi:10.3969/j.issn.1001-5256.2017.11.019

Issue 11

Nov. 2017

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2017 > 33(11): 2147-2151

PDF( 1572 KB)

Risk factors for early rebleeding after esophageal variceal ligation in patients with liver cirrhosis

DOI: 10.3969/j.issn.1001-5256.2017.11.019

First Department of Gastroenterology, Shaanxi Provincial People's Hospital

Received Date: 2017-07-19
Published Date: 2017-11-20

Abstract

Abstract

Objective To investigate the risk factors for early rebleeding after esophageal variceal ligation (EVL) in patients with liver cirrhosis.Methods A retrospective analysis was performed for the clinical data of 506 cirrhotic patients with esophageal varices who were admitted to Shaanxi Provincial People's Hospital from January 2000 to May 2016 and underwent EVL, and according to the presence or absence of early rebleeding after surgery, these patients were divided into bleeding group with 38 patients and non-bleeding group with 468 patients.The factors that could lead to postoperative rebleeding were collected.The t-test was used for comparison of normally distributed continuous data between groups, and the chi-square test was used for comparison of categorical data.An unconditional multivariate logistic regression analysis was used to investigate independent risk factors.Results The univariate analysis showed that there were significant differences between the two groups in sex (χ2=5.675) , number of times of hematemesis before treatment (t=1.335) , amount of hematemesis before treatment (χ2=1.983) , number of times of melena (t=2.984) , number of varicose veins (t=1.083) , serum prothrombin time (t=2.182) , prothrombin time activity (t=2.584) , albumin (Alb) (t=1.046) , total bilirubin (t=2.463) , aspartate transaminase (t=3.473) , severity of ascites (χ2=8.484) , Child-Pugh score (t=1.664) , Child-Pugh class (χ2=15.675) , number of ligation points (t=1.134) , and number of times of ligation (t=3.902) (all P<0.05) .The multivariate logistic regression analysis showed that male sex (odds ratio [OR]=1.598, 95% confidence interval [CI]:1.038-2.929) , Child-Pugh score>7.2 (OR=2.306, 95% CI:1.443-3.031) , and small, moderate, and large amounts of hematemesis before treatment (OR=1.342, 2.763, and 4.675, 95% CI:1.014-2.627, 1.356-4.122, and 2.321-6.929) were independent risk factors for early rebleeding after EVL (all P<0.05) , while Alb>31.5 g/L was a protective factor against early rebleeding after EVL (OR=0.411, 95% CI:0.288-0.641, P<0.05) .Conclusion Health education should be enhanced for male patients after EVL, and early correction of liver function and coagulation disorders, improvement of Alb level, prevention and treatment of ascites, and improvement in technical level of ligation may help to reduce the incidence rate of early rebleeding after EVL.
- liver cirrhosis,
- esophageal and gastric varices,
- blood loss, surgical,
- risk factors

FullText(HTML)

References(20)

References

[1]ZHENG MQ.Risk factors of early rebleeding after esophageal variceal ligation[D].Hangzhou:Zhengjiang Univ, 2009. (in Chinese) 张咩庆.食管静脉曲张套扎术后早期再出血的危险因素研究[D].杭州:浙江大学, 2009.

[2]ZHANG H, JIN J, ZUO F, et al.Observation on the efficacy of treating liver cirrhosis with esophageal varices bleeding using endoscopic ligation:56 cases[J].Shandong Med J, 2015, 55 (2) :63-65. (in Chinese) 张晖, 进军, 左凡, 等.内镜下食管静脉曲张套扎术治疗肝硬化食管静脉曲张56例疗效观察[J].山东医药, 2015, 55 (2) :63-65.

[3]LO GH, LAI KH, CHENG JL, et al.A prospective, randomized trial of sclerotherapy versus ligation in the management of bleeding esophageal varices[J].Hepatology, 1995, 22 (15) :466-471.

[4]Chinese Society of Digestive Endoscopy.Chinese Society of Digestive Endoscopy.Standard endoscopic diagnosis and treatment of esophageal and gastric varices (on trial) [J].Chin J Dig Endosc, 2000, 17 (4) :198-199. (in Chinese) 中华消化内镜学会.食管胃底静脉曲张内镜下诊断和治疗规范试行方案[J].中华消化内镜杂志, 2000, 17 (4) :198-199.

[5]SUN Y, REN TS, ZHAO QC.Analysis of drug use in 537 patients with decompensated liver cirrhosis[J].Trauma Crit Med, 2016, 4 (4) :229-235. (in Chinese) 孙滢, 任天舒, 赵庆春.肝硬化失代偿期537例患者用药分析[J].创伤与急危重病医学, 2016, 4 (4) :229-235.

[6]TSOKOS M, TURK EE.Esophageal variceal hemorrhage presenting as sudden death in outpatients[J].Arch Pathol Lab Med, 2002, 126 (12) :1197-1200.

[7]HU YW.Analysis of risk factors of rebleeding within one year after endoscopic treatment of liver cirrhosis and gastroesophageal variceal hemorrhage[D].Nanchang:Nanchang Univ, 2016. (in Chinese) 胡友文.肝硬化并食管胃静脉曲张出血内镜治疗术后1年内再出血风险因素分析[D].南昌:南昌大学, 2016.

[8]HEIKKINEN M, VSTRIK R, KARJALAINEN-LINDSBERG ML, et al.Esophageal varices and dyspnea.A clinicopathological conference report[J].Duodecim, 2014, 130 (7) :706-713.

[9]JALLI R, KAZEM HOSSEINI-ASL M, ESHRAGHIAN A, et al.Ultra-sound based techniques and transient elastography may not be precise methods for the detection of esophageal varices in liver cirrhosis[J].Med Ultrason, 2014, 16 (1) :78-79.

[10]ZHANG JP, JIANG LY, SHEN YJ.Endoscopic ligation of multiple serial of treatment of esophageal varices[J].J Changchun Univ Chin Med, 2016, 32 (4) :816-818. (in Chinese) 张金萍, 姜连英, 沈玉杰.内镜下多连环结扎术治疗食管静脉曲张的护理[J].长春中医药大学学报, 2016, 32 (4) :816-818.

[11]XU L, JI F, XU QW, ZHANG MQ, et al.Risk factors for predicting early variceal rebleeding after endoscopic variceal ligation[J].World JGastroenterol, 2011, 17 (28) :3347-3352.

[12]AL-BUSAFI SA, GHALI P, WONG P, et al.Endoscopic management of portal hypertension[J].Int J Hepatol, 2012, 12 (14) :747-752.

[13]CHEN J, ZENG XQ, MA LL, et al.Randomized controlled trial comparing endoscopic ligation with or without sclerotherapy for secondary prophylaxis of varicealbleeding[J].Eur J Gastroenterol Hepatol, 2016, 28 (1) :95-100.

[14]KAPOOR A, DHAREL N, SANYAL AJ.Endoscopic diagnosis and therapy in gastroesophageal variceal bleeding[J].Gastrointest Endosc Clin N Am, 2015, 25 (3) :491-507.

[15]KUMAR S, ASRANI SK, KAMATH PS.Epidemiology, diagnosis and early patient management of esophagogastric hemorrhage[J].Gastroenterol Clin North Am, 2014, 43 (4) :765-782.

[16]DAI C, LIU WX, JIANG M, et al.Endoscopic variceal ligation compared with endoscopic injection sclerotherapy for treatment of esophageal variceal hemorrhage:a meta-analysis[J].World J Gastroenterol, 2015, 21 (8) :2534-2541.

[17]VUACHET D, CERVONI JP, VUITTON L, et al.Improved survival of cirrhotic patients with variceal bleeding over the decade 2000-2010[J].Clin Res Hepatol Gastroenterol, 2015, 39 (1) :59-67.

[18]de FRANCHIS R, BAVENO VI FACULTY.Expanding consensus in portal hypertension:report of the Baveno VI Consensus Workshop:stratifying risk and individualizing care for portal hypertension[J].J Hepatol, 2015, 63 (3) :743-752.

[19]MOSTAFA EF, MOHAMMAD AN.Incidence and predictors of rebleeding after band ligation of oesophageal varices[J].Arab J Gastroenterol, 2014, 15 (3-4) :135-141.

[20]TRIANTOS C, KALAFATELI M.Endoscopic treatment ofesophageal varices in patients with liver cirrhosis[J].World J Gastroenterol, 2014, 20 (36) :13015-13026.

Relative Articles

[1]	Shuang ZHAO, Yuxuan ZHU, Yue LIU, Jing WANG, Qun LI, Minghui WANG, Qianqian DONG, Feifei FAN, Xiaofeng LIU. Influencing factors for rebleeding after endoscopic therapy in patients with liver cirrhosis receiving secondary prevention of gastroesophageal varices[J]. Journal of Clinical Hepatology, 2024, 40(12): 2430-2440. doi: 10.12449/JCH241213
[2]	Zhipeng CHEN, Fang YIN. Influence of patent paraumbilical vein on the development of esophageal varices and esophageal variceal bleeding in liver cirrhosis: A protective factor or a risk factor?[J]. Journal of Clinical Hepatology, 2022, 38(4): 918-922. doi: 10.3969/j.issn.1001-5256.2022.04.036
[3]	Qingjuan HE, Yingxia FANG, Xuchen LIU, Zhongbin LI. Risk factors for rebleeding after emergency esophageal variceal ligation in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2022, 38(8): 1801-1805. doi: 10.3969/j.issn.1001-5256.2022.08.016
[4]	Jia LIAN, Tao HAN, Huiling XIANG, Yankai YANG, Tinghong LI, Lei LIU, Baiguo XU, Lixia SUN, Fei WANG, Yanchao FU. Influencing factors of rebleeding after gastroscopy in patients with liver cirrhosis and esophagogastric variceal bleeding[J]. Journal of Clinical Hepatology, 2021, 37(9): 2092-2096. doi: 10.3969/j.issn.1001-5256.2021.09.018
[5]	Yan ZHANG, Huiguo DING. Risk factors for early rebleeding after endoscopic therapy for esophageal varices in cirrhotic patients[J]. Journal of Clinical Hepatology, 2021, 37(9): 2087-2091. doi: 10.3969/j.issn.1001-5256.2021.09.017
[6]	Pengpeng DING, Canghai WANG, Li LI, Jianhong CHEN, Xiaobao QI, Yanling WANG, Zheng LU, Wenhui ZHANG, Hong LIU. Risk factors for hemostatic failure in emergency gastroscopic sclerotherapy combined with tissue adhesive injection for esophagogastric variceal bleeding with portal vein embolus[J]. Journal of Clinical Hepatology, 2021, 37(1): 68-72. doi: 10.3969/j.issn.1001-5256.2021.01.014
[7]	Yingying CAO, Tao HAN, Yu ZHANG, Fang LIU, Jing LIANG, Haixia YUAN, Jun LI, Huiling XIANG. Rebleeding and prognosis of patients with liver cirrhosis and severe esophagogastric variceal bleeding[J]. Journal of Clinical Hepatology, 2021, 37(6): 1326-1330. doi: 10.3969/j.issn.1001-5256.2021.06.022
[8]	Huaiwen ZUO, Qimei SHA, Jiao SUN, Zhihui CAI, Hongwei XU, Hui LIU. Risk factors of portal vein thrombosis in cirrhotic patients with esophageal varices[J]. Journal of Clinical Hepatology, 2021, 37(1): 63-67. doi: 10.3969/j.issn.1001-5256.2021.01.013
[9]	Ruan FangMing, Li BiMin. Risk factors for the formation of portal vein thrombosis in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2020, 36(1): 182-185. doi: 10.3969/j.issn.1001-5256.2020.01.043
[10]	Yao YunHai, Luo Yan, Zhu JingLe, Gan JianHe, Zhao WeiFeng. Risk factors for hepatic encephalopathy after emergency transjugular intrahepatic portosystemic shunt for patients with acute esophagogastric variceal bleeding[J]. Journal of Clinical Hepatology, 2020, 36(2): 343-347. doi: 10.3969/j.issn.1001-5256.2020.02.022
[11]	Lyu Jing, Dong SiSi, Gu HongTu, Zhao ZhangQing, Liu ChengHai. TCM syndrome characteristics of portal vein thrombosis in patients with liver cirrhosis and related risk factors[J]. Journal of Clinical Hepatology, 2019, 35(10): 2210-2213. doi: 10.3969/j.issn.1001-5256.2019.10.016
[12]	Sun YaNan, Li Peng, Ding HuiGuo, Zhang ShiBin, Xiong Feng. Risk factors for early rebleeding after initial sclerotherapy for esophageal varices[J]. Journal of Clinical Hepatology, 2019, 35(1): 92-97. doi: 10.3969/j.issn.1001-5256.2019.01.017
[13]	Cui CanCan, Li DanDan, Li ZhangFeng, Yan ZhenKun, Wang LiQiang, Sun Chen, Zhang Ke, Zhang Bin. Risk factors for early rebleeding after first-time endoscopic variceal ligation[J]. Journal of Clinical Hepatology, 2018, 34(7): 1445-1451. doi: 10.3969/j.issn.1001-5256.2018.07.017
[14]	Ma JiaLi, Li Ping, Wei HongShan, Zhou YuLing, Liang XiuXia, Hu JuLong, Ai ZhengLin, Chen Xu. Risk factors for glue extrusion bleeding after endoscopic therapy for esophagogastric variceal bleeding[J]. Journal of Clinical Hepatology, 2018, 34(1): 89-91. doi: 10.3969/j.issn.1001-5256.2018.01.018
[15]	He Yang, Su YaRong, Han ZiYan. Current status of research on primary and secondary risk factors for esophagogastric variceal rebleeding in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2018, 34(7): 1555-1559. doi: 10.3969/j.issn.1001-5256.2018.07.041
[16]	Zhou RenHua, Li Peng, Zhang YanTing, Yang Hua, Yang ShaoQi. Clinical manifestations of portal vein thrombosis and related risk factors in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2016, 32(2): 275-278. doi: 10.3969/j.issn.1001-5256.2016.02.015
[17]	Gu Chuan, Li Lu, Wang Jun, Hou FengQin, Xu XiaoYuan. Study on efficacy of endoscopic ligation therapy for esophageal varices and risk factors for postoperative rebleeding[J]. Journal of Clinical Hepatology, 2014, 30(12): 1279-1282. doi: 10.3969/j.issn.1001-5256.2014.12.011
[18]	Yang Hua, Liu YunXia, Li Peng, Yang ShaoQi, Wang YuanZhen. Analysis of risk factors for early rebleeding from esophageal and gastric varices in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2014, 30(6): 540-542. doi: 10.3969/j.issn.1001-5256.2014.06.015
[19]	Yang Yan, Fan YanHua, Fang Long, Gao Chun, Du ShiYu, Zhang MingGang, Wang YuanXin, Zhang KeJian. Risk factors of early rebleeding after endoscopic treatment of gastroesophageal varices[J]. Journal of Clinical Hepatology, 2013, 29(3): 178-183.
[20]	Shao CuiPing, Xu XiaoYuan. Progress in the prevention and treatment of bleeding gastroesophageal varices in patients with cirrhosis[J]. Journal of Clinical Hepatology, 2012, 28(9): 647-650.

Supplements(0)

Cited By

Cited by

Periodical cited type(13)

1.	尚华，张国顺，王素颖，王志源，吴贵恺，吴迪杨，王柳青，魏红山. 肝硬化食道胃底曲张静脉破裂出血内镜下治疗后再出血的影响因素分析. 中国煤炭工业医学杂志. 2022(01): 40-45 .
2.	邓悦，姚欢，谢宇欣，石国庆. 肝硬化食管胃静脉曲张内镜下治疗后营养支持治疗的研究进展. 海南医学. 2022(04): 522-525 .
3.	贺庆娟，房英霞，刘旭臣，李忠斌. 肝硬化食管静脉曲张急诊套扎术后再出血的影响因素. 临床肝胆病杂志. 2022(08): 1801-1805 . 本站查看
4.	刘瑞生，丁士刚. 静脉曲张套扎术在食管静脉曲张中的应用进展. 中国微创外科杂志. 2021(04): 362-365 .
5.	陈雪芬，黄小英，许耀斌，许秋泳. 基于微信的延续护理在食管静脉曲张套扎术后患者的应用效果. 福建医药杂志. 2020(06): 143-145 .
6.	张昊. 健康教育及心理护理干预对肝硬化患者食道静脉曲张套扎术后再出血的影响. 医学理论与实践. 2020(24): 4203-4205 .
7.	刘庆伟，王婧，刘静，陈宁，焦建新. 肝硬化食管静脉曲张首次套扎术后再出血危险因素分析. 世界最新医学信息文摘. 2019(59): 33-34+36 .
8.	黄理，陈丽芬，蓝婧，姚朝光，覃冬林，满桂月，吴晓云，韦巍巍，黄云美. 肝硬化食管静脉曲张内镜下治疗后早期再出血的危险因素研究. 现代消化及介入诊疗. 2019(09): 1035-1038 .
9.	崔璨璨，李丹丹，李长锋，闫振坤，王丽强，孙晨，张克，张斌. 食管静脉曲张首次套扎术后早期再出血的危险因素分析. 临床肝胆病杂志. 2018(07): 1445-1451 . 本站查看
10.	何阳，苏亚荣，韩子岩. 肝硬化食管胃静脉曲张破裂再出血的主次危险因素研究现状. 临床肝胆病杂志. 2018(07): 1555-1559 . 本站查看
11.	崔美兰，贾彦生，闫会敏，康海燕，王艳，殷树英，郑欢伟. 内镜下密集套扎法治疗食管静脉曲张破裂出血的效果观察. 临床肝胆病杂志. 2018(08): 1683-1688 . 本站查看
12.	孙鑫，宋明全. 食管胃底静脉曲张破裂出血内镜下治疗进展. 世界华人消化杂志. 2018(26): 1562-1566 .
13.	张敏. 内镜套扎术联合生长抑素治疗肝硬化伴食管静脉曲张破裂出血的疗效观察. 海峡药学. 2018(09): 157-158 .

Other cited types(5)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (2504) PDF downloads(438)

Risk factors for early rebleeding after esophageal variceal ligation in patients with liver cirrhosis

DOI: 10.3969/j.issn.1001-5256.2017.11.019